Joseph P Lyssikatos's Net Worth
$2.33 Million
Who is Joseph P Lyssikatos?
Joseph P Lyssikatos has an estimated net worth of $2.33 Million. This is based on reported shares in Enliven Therapeutics, Inc..
SEC CIK
Joseph P Lyssikatos's CIK is 0001967150
Past Insider Trading and Trends
2023 was Joseph P Lyssikatos's most active year for acquiring shares with 10 total transactions. Joseph P Lyssikatos's most active month to acquire stocks was the month of November. 2024 was Joseph P Lyssikatos's most active year for disposing of shares, totalling 17 transactions. Joseph P Lyssikatos's most active month to dispose stocks was the month of November. 2024 saw Joseph P Lyssikatos paying a total of $100,800.00 for 275,000 shares, this is the most they've acquired in one year. In 2024 Joseph P Lyssikatos cashed out on 180,000 shares for a total of $1,837,528.30, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Enliven Therapeutics, Inc. (ELVN) Snapshot price: $21.44
CHIEF SCIENTIFIC OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.08% | -847.00 |
$30.00 | -$25,412.54 | 1.02M |
Scheduled
|
Oct 18
| ||
Form 4
| -1.10% | -12.00K |
$22.49 | -$269,841.38 | 1.08M |
Scheduled
|
Aug 29
| ||
Form 4
| -0.28% | -3.10K |
$27.56 | -$85,399.45 | 1.09M |
Scheduled
|
Jul 31
| ||
Form 4
| -1.09% | -12.00K |
$26.70 | -$320,377.80 | 1.09M |
Scheduled
|
Jul 29
| ||
Form 4
| -1.07% | -12.00K |
$22.89 | -$274,736.40 | 1.11M |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$11.43 | -$247,360.14 |
0
|
Scheduled
|
May 29
| ||
Form 4
|
—
|
0
|
$9.52 | -$201,547.75 |
0
|
Scheduled
|
Apr 29
| ||
Form 4
|
—
|
0
|
$13.08 | -$717,732.00 |
0
|
Scheduled
|
Apr 11
| ||
Form 4
|
—
|
0
|
$9.86 | -$209,705.71 |
0
|
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$8.77 | -$183,566.30 |
0
|
Scheduled
|
Feb 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
$8.49 | -$176,816.40 |
0
|
Scheduled
|
Jan 29
| ||
Form 4
|
—
|
0
|
$7.70 | -$157,941.29 |
0
|
Scheduled
|
Dec 29
| ||
Form 4
|
—
|
0
|
$7.10 | -$78,436.12 |
0
|
Scheduled
|
Dec 21 - Dec 22
| ||
Form 4
|
—
|
0
|
$7.07 | -$105,691.09 |
0
|
Scheduled
|
Dec 19 - Dec 20
| ||
Form 4
|
—
|
0
|
$7.10 | -$102,179.39 |
0
|
Scheduled
|
Nov 3
| ||
Form 4
|
—
|
0
|
$7.37 | -$150,057.60 |
0
|
Sep 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
|
∞
| 1.12M |
—
|
—
| 1.12M |
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||